Subsequent malignant neoplasms (SMNs) are one of the most serious and potentially lethal complications of cancer and its therapy. Radiotherapy has been known to be a…
Month: October 2018
Oct 29 
Meeting the Unmet Need for Oral Mucositis
Oral Mucositis (OM) refers to erythematous and ulcerative lesions of the oral mucosa observed in cancer patients under chemotherapy or radiation therapy. In its severe form,…
Oct 25 
The Business Cocktail
Innovent Biologics reaps USD 421 Million by Hong Kong IPO Innovent Biologics got delivered USD 421 million in its IPO. The Suzhou-based unicorn priced 236.35 million…
Oct 22 
INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER
To know more about TRIPLE NEGATIVE BREAST CANCER request for sample pages: https://www.delveinsight.com/dev-sample.php?form_name=Triple-Negative-Breast-Cancer-(TNBC)—Market-Insight,-Epidemiology-and-Market-Forecast-2027
Oct 18 
The Business Cocktail
Novartis signs USD 2.1Billion for Endocyte acquisition Novartis has inked USD 2.1 billion agreement to takeover Endocyte. Endocyte, a biopharmaceutical company, headquartered in Indiana, licensed the cancer drug…
Oct 17 
Drugmakers will now have to reveal medicine prices in television ads
Pharmaceutical companies will disclose the price of medicines in television advertisements to consumers. The step is taken up by the Trump administration to control rampant spending…
Oct 12 
Is Gene Therapy the Next Cancer Treatment Revolution?
Gene Therapy is now touted as a new revolution for cancer treatment. If the list of new cancer treatment methodologies is traversed, then the end seems…
